Indegene Limited (NSE: INDGN)
India
· Delayed Price · Currency is INR
629.60
-10.55 (-1.65%)
Jan 17, 2025, 10:26 AM IST
Indegene Revenue
Indegene had revenue of 6.87B INR in the quarter ending September 30, 2024, with 13.05% growth. This brings the company's revenue in the last twelve months to 27.10B. In the fiscal year ending March 31, 2024, Indegene had annual revenue of 25.90B with 12.29% growth.
Revenue (ttm)
27.10B
Revenue Growth
+12.29%
P/S Ratio
5.49
Revenue / Employee
6.20M
Employees
4,367
Market Cap
155.87B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 25.90B | 2.84B | 12.29% |
Mar 31, 2023 | 23.06B | 6.41B | 38.54% |
Mar 31, 2022 | 16.65B | 6.84B | 69.76% |
Mar 31, 2021 | 9.81B | 3.37B | 52.36% |
Mar 31, 2020 | 6.44B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 503.08B |
Divi's Laboratories | 86.14B |
Cipla | 262.64B |
Mankind Pharma | 110.18B |
Zydus Lifesciences | 214.84B |
Apollo Hospitals Enterprise | 204.69B |
Aurobindo Pharma | 302.95B |
Alkem Laboratories | 128.32B |